glp 1 agonist dementia Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease Mapping the effectiveness and risks

Their benefits now extend well beyond glycemic control and weight loss, with growing evidence supporting their use in the management of steatosis liver disease, obstructive sleep apnea, cardiovascular disease, and chronic kidney disease

Preliminary clinical evidence supports this hypothesisstudies in obese individuals treated with tirzepatide have shown a downward trend in the apneahypopnea index (AHI), suggesting that tirzepatide may have a beneficial effect on sleep-disordered breathing (28)

Since its approval for the treatment of diabetes, it has caught the attention of scientists and clinicians alike, as it was noted that patients using this drug for diabetes management also lost weight

doi: 10.1016/j.cmet.2022.07.013 80 le RouxCWSteenOLucasKJStartsevaEUnseldAHennigeAM

However, with increasing competition in the GLP-1 RA market, merely relying on efficacy is no longer sufficient for a product to stand out

The most common side effects of Saxenda include: Headache Injection site reactions Constipation Stomach pain Heartburn Fatigue Runny nose, sneezing or coughing Less common but more serious side effects may include: Pancreatitis Increased heart rate An increased risk of gallbladder disease Low blood sugar (hypoglycemia) Kidney problems Increased risk of thyroid cancer or tumors Suicidal thoughts Allergic reactions like skin rash, swelling, breathing difficulties Saxenda may not be safe for certain individuals with previously diagnosed medical conditions